Netherlands· NL-1fc819889e0f
Zemcelpro ¿ 0,23 × 106 levensvatbare CD34+-cellen/ml / ¿ 0,53 × 106 levensvatbare CD3+-cellen/ml dispersie voor infusie
A stammzellen aus nabelschnurblut product containing allogene navelstreng-afgeleid cd34- cellen, niet geëxpandeerd + dorocubicel, registered in Netherlands by Cordex Biologics International Limited. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Stammzellen aus nabelschnurblut is registered in 8 of 19 countries.
Countries holding a registration under ATC B05AX04 (stammzellen aus nabelschnurblut), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Stammzellen aus nabelschnurblut · ATC B05AX04
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ALLOGENE NAVELSTRENG-AFGELEID CD34- CELLEN, NIET GEËXPANDEERD + DOROCUBICEL
- Manufacturer
- Cordex Biologics International Limited
- Country
- Netherlands (NL)
- ATC code
- B05AX04
- ATC class
- Stammzellen aus Nabelschnurblut
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/25/1960
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B05AX04
Stammzellen aus nabelschnurblut, as other registers publish it.
- IcelandZemcelproCordex Biologics International Limited
- PolandZemcelproCordex Biologics International Limited
- FinlandZemcelproCordex Biologics International Limited
- DenmarkZemcelproCordex Biologics International Limited
- CzechiaZEMCELPROCordex Biologics International Limited, Dublin
- IrelandZemcelpro ≥ 0.23×106 viable CD34+ cells/mL/≥ 0.53×106 viable CD3+ cells/mL dispersion for infusionCordex Biologics International Limited
- BelgiumZemcelpro 0.23 10*6 cells/ml - 0.53 10*6 cells/mlCordex Biologics International
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6092a497-31d2-4782-a088-3838f0806e9a GET /v1/drugs/6092a497-31d2-4782-a088-3838f0806e9a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersie voor infusie",
"route": "Intraveneus gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/zemcelpro-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Stem cells from umbilical cord blood",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp132669",
"excipients": [
"DIMETHYLSULFOXIDE",
"DIMETHYLSULFOXIDE",
"HUMAAN ALBUMINE OPLOSSING",
"HUMAAN ALBUMINE OPLOSSING",
"KALIUMCHLORIDE (E 508)",
"KALIUMCHLORIDE (E 508)",
"MAGNESIUMCHLORIDE 6-WATER (E 511)",
"MAGNESIUMCHLORIDE 6-WATER (E 511)",
"NATRIUMACETAAT 3-WATER (E 262)",
"NATRIUMACETAAT 3-WATER (E 262)",
"NATRIUMCHLORIDE",
"NATRIUMCHLORIDE",
"NATRIUMGLUCONAAT (E 576)",
"NATRIUMGLUCONAAT (E 576)"
],
"substances": [
"ALLOGENE NAVELSTRENG-AFGELEID CD34- CELLEN, NIET GEËXPANDEERD",
"DOROCUBICEL"
],
"leaflet_url": null,
"authorised_at": "2025/08/25",
"procedure_number": "EMEA/H/C/005772",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/25/1960",
"additional_monitoring": "Y"
}See everything about stammzellen aus nabelschnurblut.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.